EXONHIT Trademark

Trademark Overview


On Wednesday, November 30, 2011, a trademark application was filed for EXONHIT with the United States Patent and Trademark Office. The USPTO has given the EXONHIT trademark a serial number of 79111670. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 30, 2021. This trademark is owned by EXONHIT S.A.. The EXONHIT trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the treatment of diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents, consumables and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products, namely, reagents, consumables, chemical entities a...

Chemical products and compositions, namely, nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research, namely, reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely, blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses, namely, nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant h...

Medical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services

Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purpos...

Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology
exonhit

General Information


Serial Number79111670
Word MarkEXONHIT
Filing DateWednesday, November 30, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 30, 2021
Registration Number4281253
Registration DateTuesday, January 29, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements


Description of MarkThe mark consists of the wording "EXONHIT" in stylized format. "EXON" is in grey and "HIT" is in burgundy.
Goods and ServicesPharmaceutical products for the treatment of diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents, consumables and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products, namely, reagents, consumables, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer ; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing Alzheimer disease and other neurodegenerative diseases and cancer, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis comprised of nucleic acid libraries and nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents contained in diagnostic test kits for medical use for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions
Indication of Colors claimedThe color(s) grey and burgundy is/are claimed as a feature of the mark.
Goods and ServicesChemical products and compositions, namely, nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research, namely, reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely, blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses, namely, nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, libraries of nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for leading research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, DNA fragments for decoding genes affected by diseases or for revealing the transcriptomic signature of patients affected by diseases, and DNA fragments for revealing and analyzing the expression of genes in connection with human medicine, pharmacological medicine and veterinary science
Goods and ServicesMedical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services
Goods and ServicesSurgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purposes; syringes for medical purposes
Goods and ServicesResearch and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 30, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDIAXONHIT
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameEXONHIT S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameEXONHIT S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Sunday, June 26, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, June 26, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 17, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Monday, June 15, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, June 15, 2020INVALIDATION PROCESSED
Thursday, April 30, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 30, 2019CANCELLED SECTION 71
Monday, January 29, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 20, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, May 25, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 29, 2013FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 29, 2013FINAL DISPOSITION PROCESSED
Monday, April 29, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 29, 2013REGISTERED-PRINCIPAL REGISTER
Sunday, November 18, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 24, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 9, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 5, 2012ASSIGNED TO LIE
Saturday, September 22, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 21, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 21, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 21, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 27, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 27, 2012FINAL REFUSAL E-MAILED
Monday, August 27, 2012FINAL REFUSAL WRITTEN
Monday, July 23, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 23, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 23, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 23, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 11, 2012REFUSAL PROCESSED BY IB
Friday, May 18, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 18, 2012REFUSAL PROCESSED BY MPU
Thursday, May 17, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 16, 2012NON-FINAL ACTION WRITTEN
Monday, May 14, 2012ASSIGNED TO EXAMINER
Tuesday, May 8, 2012APPLICATION FILING RECEIPT MAILED
Friday, May 4, 2012ASSIGNED TO EXAMINER
Friday, May 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 3, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB